Chemoinformaics analysis of 14-Oxy-alpha-muurolene
Molecular Weight | 450.66 | nRot | 5 |
Heavy Atom Molecular Weight | 404.292 | nRig | 24 |
Exact Molecular Weight | 450.335 | nRing | 4 |
Solubility: LogS | -2.374 | nHRing | 0 |
Solubility: LogP | 6.547 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 27 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 79.7725 |
nHD | 4 | BPOL | 47.0155 |
QED | 0.522 |
Synth | 3.231 |
Natural Product Likeliness | 2.48 |
NR-PPAR-gamma | 0.931 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.766 |
Pgp-sub | 0.002 |
HIA | 0.073 |
CACO-2 | -4.744 |
MDCK | 0.0000169 |
BBB | 0.003 |
PPB | 0.959011 |
VDSS | 0.48 |
FU | 0.0667357 |
CYP1A2-inh | 0.511 |
CYP1A2-sub | 0.391 |
CYP2c19-inh | 0.937 |
CYP2c19-sub | 0.067 |
CYP2c9-inh | 0.914 |
CYP2c9-sub | 0.936 |
CYP2d6-inh | 0.478 |
CYP2d6-sub | 0.457 |
CYP3a4-inh | 0.37 |
CYP3a4-sub | 0.145 |
CL | 2.38 |
T12 | 0.112 |
hERG | 0.06 |
Ames | 0.035 |
ROA | 0.959 |
SkinSen | 0.579 |
Carcinogencity | 0.599 |
EI | 0.029 |
Respiratory | 0.563 |
NR-Aromatase | 0.869 |
Antiviral | Yes |
Prediction | 0.790877 |